Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK)
8049.HK Stock Price Chart
Explore Jilin Province Huinan Changlong Bio-pharmacy Company Limited interactive price chart. Choose custom timeframes to analyze 8049.HK price movements and trends.
8049.HK Company Profile
Discover essential business fundamentals and corporate details for Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
24 May 2001
Employees
745.00
Website
https://www.jlchanglong.comCEO
Hong Zhang
Description
Jilin Province Huinan Changlong Bio-pharmacy Company Limited engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People's Republic of China. It offers tablets, capsules, pills, Chinese medicine pretreatment and extraction products, powders for injections, lyophilized powder for injections, small volume injection solutions, APIs, and granules. The company markets its products under the Changlong and Qing Tong brands. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.
8049.HK Financial Timeline
Browse a chronological timeline of Jilin Province Huinan Changlong Bio-pharmacy Company Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 30 Mar 2026
Upcoming earnings on 30 Mar 2026
Earnings released on 14 Aug 2025
Dividend declared on 24 Jun 2025
A dividend of $0.27 per share was announced, adjusted to $0.27. The dividend was paid on 18 Jul 2025.
Earnings released on 31 Mar 2025
Earnings released on 28 Mar 2025
Earnings released on 19 Nov 2024
Earnings released on 14 Aug 2024
EPS came in at $0.10 , while revenue for the quarter reached $211.07M .
Dividend declared on 18 Jun 2024
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 16 Jul 2024.
Earnings released on 25 Apr 2024
EPS came in at $0.10 , while revenue for the quarter reached $212.64M .
Earnings released on 28 Mar 2024
EPS came in at $0.03 , while revenue for the quarter reached $275.27M .
Earnings released on 14 Nov 2023
EPS came in at $0.10 , while revenue for the quarter reached $211.51M .
Earnings released on 14 Aug 2023
EPS came in at $0.05 , while revenue for the quarter reached $273.70M .
Dividend declared on 8 Jun 2023
A dividend of $0.55 per share was announced, adjusted to $0.55. The dividend was paid on 30 Jun 2023.
Earnings released on 20 Apr 2023
EPS came in at $0.18 , while revenue for the quarter reached $282.65M .
Earnings released on 31 Mar 2023
EPS came in at $0.11 , while revenue for the quarter reached $162.71M .
Earnings released on 30 Sept 2022
EPS came in at $0.05 , while revenue for the quarter reached $237.41M .
Dividend declared on 26 Jul 2022
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 31 Aug 2022.
Earnings released on 30 Jun 2022
EPS came in at $0.09 , while revenue for the quarter reached $215.32M .
Earnings released on 31 Mar 2022
EPS came in at $0.07 , while revenue for the quarter reached $238.31M .
Earnings released on 31 Dec 2021
EPS came in at $0.10 , while revenue for the quarter reached $283.80M .
Dividend declared on 15 Oct 2021
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 18 Nov 2021.
Earnings released on 30 Sept 2021
EPS came in at $0.10 , while revenue for the quarter reached $207.86M .
Dividend declared on 9 Jul 2021
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 30 Aug 2021.
Earnings released on 30 Jun 2021
EPS came in at $0.06 , while revenue for the quarter reached $183.23M .
Earnings released on 31 Mar 2021
EPS came in at $0.04 , while revenue for the quarter reached $176.11M .
Earnings released on 31 Dec 2020
EPS came in at $0.09 , while revenue for the quarter reached $215.89M .
Earnings released on 30 Sept 2020
EPS came in at $0.06 , while revenue for the quarter reached $176.54M .
8049.HK Stock Performance
Access detailed 8049.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.